Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Isabelle Colle & Pierre-François Laterre. (2018) Hepatorenal syndrome: the clinical impact of vasoactive therapy. Expert Review of Gastroenterology & Hepatology 12:2, pages 173-188.
Read now
Read now
Søren Møller & Flemming Bendtsen. (2015) Complications of cirrhosis. A 50 years flashback. Scandinavian Journal of Gastroenterology 50:6, pages 763-780.
Read now
Read now
Paolo Angeli. (2013)
Terlipressin for the treatment of hepatorenal syndrome in patients with cirrhosis. Expert Opinion on Orphan Drugs 1:3, pages 241-248.
Read now
Read now
Raphaël Favory, Diamantino R Salgado & Jean-Louis Vincent. (2009) Investigational vasopressin receptor modulators in the pipeline. Expert Opinion on Investigational Drugs 18:8, pages 1119-1131.
Read now
Read now
J. H. Henriksen. (2004) Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 64:6, pages 523-534.
Read now
Read now
Articles from other publishers (34)
Florence Wong. (2023) Management of Portal Hypertension in Patients with Acute-on-Chronic Liver Disease. Clinics in Liver Disease 27:3, pages 717-733.
Crossref
Crossref
L. Ibáñez-Samaniego, A. Baines & R. Bañares. (2023) Afectación renal en la enfermedad hepática crónica avanzada. Síndrome hepatorrenal. Medicine - Programa de Formación Médica Continuada Acreditado 13:82, pages 4841-4849.
Crossref
Crossref
Constantine J. KarvellasRam SubramanianJody C. OlsonKhurram Jamil. (2023) Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial. Critical Care Explorations 5:4, pages e0890.
Crossref
Crossref
Florence Wong. 2023. Cardio-Hepatology. Cardio-Hepatology
275
291
.
Florence Wong & Tilman Sauerbruch. 2022. Pharmacotherapy for Liver Cirrhosis and Its Complications. Pharmacotherapy for Liver Cirrhosis and Its Complications
149
166
.
Florence WongS. Chris PappasMichael P. CurryK. Rajender ReddyRaymond A. RubinMichael K. PoraykoStevan A. GonzalezKhalid MumtazNicholas LimDouglas A. SimonettoPratima SharmaArun J. SanyalMarlyn J. MayoR. Todd FrederickShannon EscalanteKhurram Jamil. (2021) Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. New England Journal of Medicine 384:9, pages 818-828.
Crossref
Crossref
Florence Wong. (2020) Latest Treatment of Acute Kidney Injury in Cirrhosis. Current Treatment Options in Gastroenterology 18:2, pages 281-294.
Crossref
Crossref
Ahmed Mukhtar, Ahmed Lotfy, Amr Hussein & Eman Fouad. (2020) Splanchnic and systemic circulation cross talks: Implications for hemodynamic management of liver transplant recipients. Best Practice & Research Clinical Anaesthesiology 34:1, pages 109-118.
Crossref
Crossref
Ahmed M. Mukhtar. 2019. Critical Care for Potential Liver Transplant Candidates. Critical Care for Potential Liver Transplant Candidates
55
68
.
晓筠 杨. (2018) Experience of Terlipressin in the Treatment of Hepatic Hydrothorax (a Report of 2 Cases). Advances in Clinical Medicine 08:07, pages 657-662.
Crossref
Crossref
Florence Wong. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
262
280.e5
.
Kannan Sridharan & Gowri Sivaramakrishnan. (2017) Vasoactive Agents for Hepatorenal Syndrome: A Mixed Treatment Comparison Network Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials. Journal of General Internal Medicine 33:1, pages 97-102.
Crossref
Crossref
Troels M. Busk, Flemming Bendtsen, Jens H. Henriksen, Stefan Fuglsang, Jens O. Clemmesen, Fin S. Larsen & Søren Møller. (2017) Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis. Digestive and Liver Disease 49:12, pages 1353-1359.
Crossref
Crossref
Tary A. Salman, Ahmed M. Edrees, Hala H. El-Said, Osama L. El-Abd & Gasser I. El-Azab. (2016) Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology 28:7, pages 777-785.
Crossref
Crossref
Thomas D. Boyer, Arun J. Sanyal, Florence Wong, R. Todd Frederick, John R. Lake, Jacqueline G. O’Leary, Daniel Ganger, Khurram Jamil, Stephen Chris Pappas, Samuel H. Sigal, Santiago J. Munoz, Vishal Patel, Paul Y. Kwo, Jasmohan S. Bajaj, Tarek I. Hassanein, Kirti Shetty, Rohit Satoskar, K. Rajender Reddy, Marlyn Mayo, Victor Araya, Nikroo Hashemi, Eyob Feyssa, Lorenzo Rossaro, David Kravetz, Priya Grewal, Ram Subramanian, Kevin Korenblat, Yuri Stepanovich Genyk, Fredric Regenstein, Joseph F. Buell, Nathan J. Shores, Sukru H. Emre, Andrea Duchini, Atif Zaman, Marco Antonio Olivera-Martinez, Michael K. Porayko, Alex S. Befeler, K. Gautham Reddy, Maria Del Pilar Hernandez, Stephen D. Zucker, Hugo E. Vargas, Michael Curry, Adnan Said, Kris V. Kowdley, Terry Box, David Shields Barnes, Marie Noëlle Pépin, Madhavi Rudraraju, Paul Angulo, Howard P. Monsour, David Wolf, Charles Howell, Fredric G. Regenstein, Antonio Sanchez, Hany Elbeshbeshy, Michael B. Fallon, Colin Swales, David A. Sass, Eva Urtasun Sotil, Brendan McGuire, Richard K. Gilroy, Juan A. Guerrero, Mark N. Wong, Obaid Shaikh, Stevan Gonzalez & Zeid Kayali. (2016) Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Gastroenterology 150:7, pages 1579-1589.e2.
Crossref
Crossref
Ahmed Mukhtar. (2016) Modulation of splanchnic circulation: Role in perioperative management of liver transplant patients. World Journal of Gastroenterology 22:4, pages 1582.
Crossref
Crossref
Y.J. Won, H.J. Kim, B.G. Lim, H.S. Ahn, M.H. Hwang & I.O. Lee. (2015) Effect of Perioperative Terlipressin on Postoperative Renal Function in Patients Who Have Undergone Living Donor Liver Transplantation: A Meta-Analysis of Randomized Controlled Trials. Transplantation Proceedings 47:6, pages 1917-1925.
Crossref
Crossref
Ahmed Mukhtar, Ihab Mahmoud, Gihan Obayah, Ahmed Hasanin, Fawzia Aboul-Fetouh, Hany Dabous, Mohamed Bahaa, Amr Abdelaal, Mohamed Fathy & Mahmoud El Meteini. (2015) Intraoperative Terlipressin Therapy Reduces the Incidence of Postoperative Acute Kidney Injury After Living Donor Liver Transplantation. Journal of Cardiothoracic and Vascular Anesthesia 29:3, pages 678-683.
Crossref
Crossref
Florence Wong. 2015. Cirrhosis: A practical guide to management. Cirrhosis: A practical guide to management
175
188
.
Kurt Lenz, Robert Buder, Lisbeth Kapun & Martin Voglmayr. (2014) Treatment and management of ascites and hepatorenal syndrome: an update. Therapeutic Advances in Gastroenterology 8:2, pages 83-100.
Crossref
Crossref
Marta Cavallin, Silvano Fasolato, Simona Marenco, Salvatore Piano, Marta Tonon & Paolo Angeli. (2015) The Treatment of Hepatorenal Syndrome. Digestive Diseases 33:4, pages 548-554.
Crossref
Crossref
Antonio Paulo Nassar Junior, Alberto Queiroz Farias, Luiz Augusto Carneiro d’ Albuquerque, Flair José Carrilho & Luiz Marcelo Sá Malbouisson. (2014) Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. PLoS ONE 9:9, pages e107466.
Crossref
Crossref
Paolo Angeli, Arun Sanyal, Soren Moller, Carlo Alessandria, Adrian Gadano, Ray Kim, Shiv K. Sarin & Mauro Bernardi. (2012)
Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the
I
nternational
C
lub of
A
scites
. Liver International 33:1, pages 16-23.
Crossref
Crossref
Y-Y Huang, J-Y Sun, J-Y Wang, C-X Bai & B-M He. (2012) Terlipressin Resolves Ascites of Cirrhotic Rats through Downregulation of Aquaporin 2. Journal of International Medical Research 40:5, pages 1735-1744.
Crossref
Crossref
Joao Felipe de Brito Galvao & Sharon A. Center. 2012. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
456
499
.
Wesley Leung & Florence Wong. (2011) Hepatorenal Syndrome: Do the Vasoconstrictors Work?. Gastroenterology Clinics of North America 40:3, pages 581-598.
Crossref
Crossref
Harshal Rajekar & Yogesh Chawla. (2011) Terlipressin in hepatorenal syndrome: Evidence for present indications. Journal of Gastroenterology and Hepatology 26, pages 109-114.
Crossref
Crossref
George Kalambokis, Spyridon Tsiouris, Epameinondas V. Tsianos, Gerasimos Baltayiannis, Barbara Pakou & Andreas Fotopoulos. (2010) Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis. Liver International 30:9, pages 1371-1378.
Crossref
Crossref
Pierre Asfar, Peter Radermacher, Paul Calès & Frédéric Oberti. (2010) The effects of vasopressin and its analogues on the liver and its disorders in the critically ill. Current Opinion in Critical Care 16:2, pages 148-152.
Crossref
Crossref
Natalie F. Holt & Kenneth L. Haspel. (2010) Vasopressin: A Review of Therapeutic Applications. Journal of Cardiothoracic and Vascular Anesthesia 24:2, pages 330-347.
Crossref
Crossref
Linda E. Muñoz, Eliud G. Alcalá, Paula Cordero, Manuel A. Martinez, Nathalie Y. Vázquez, Susana Galindo, Eduardo Mendoza & José J. Segura. (2009) Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico. Annals of Hepatology 8:3, pages 207-211.
Crossref
Crossref
Aleksander Krag, Tine Borup, Søren Møller & Flemming Bendtsen. (2008) Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Advances in Therapy 25:11, pages 1105-1140.
Crossref
Crossref
Aleksander Krag, Søren Møller, Jens H. Henriksen, Niels-Henrik Holstein-Rathlou, Fin Stolze Larsen & Flemming Bendtsen. (2007) Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology 46:6, pages 1863-1871.
Crossref
Crossref
Sharon A. Center. 2006. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
437
477
.